rs635132
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_015295.3(SMCHD1):āc.1851A>Gā(p.Thr617=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.702 in 1,550,818 control chromosomes in the GnomAD database, including 389,900 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.61 ( 30718 hom., cov: 28)
Exomes š: 0.71 ( 359182 hom. )
Consequence
SMCHD1
NM_015295.3 synonymous
NM_015295.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.334
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 18-2705702-A-G is Benign according to our data. Variant chr18-2705702-A-G is described in ClinVar as [Benign]. Clinvar id is 260633.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-2705702-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.334 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMCHD1 | NM_015295.3 | c.1851A>G | p.Thr617= | synonymous_variant | 14/48 | ENST00000320876.11 | NP_056110.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMCHD1 | ENST00000320876.11 | c.1851A>G | p.Thr617= | synonymous_variant | 14/48 | 5 | NM_015295.3 | ENSP00000326603 | P2 | |
ENST00000583546.1 | n.371-13822T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.612 AC: 92435AN: 150978Hom.: 30704 Cov.: 28
GnomAD3 genomes
AF:
AC:
92435
AN:
150978
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.694 AC: 167030AN: 240620Hom.: 59460 AF XY: 0.695 AC XY: 90941AN XY: 130864
GnomAD3 exomes
AF:
AC:
167030
AN:
240620
Hom.:
AF XY:
AC XY:
90941
AN XY:
130864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.712 AC: 996360AN: 1399724Hom.: 359182 Cov.: 21 AF XY: 0.710 AC XY: 496261AN XY: 699028
GnomAD4 exome
AF:
AC:
996360
AN:
1399724
Hom.:
Cov.:
21
AF XY:
AC XY:
496261
AN XY:
699028
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.612 AC: 92474AN: 151094Hom.: 30718 Cov.: 28 AF XY: 0.615 AC XY: 45350AN XY: 73798
GnomAD4 genome
AF:
AC:
92474
AN:
151094
Hom.:
Cov.:
28
AF XY:
AC XY:
45350
AN XY:
73798
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2301
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 24, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Facioscapulohumeral muscular dystrophy 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Arrhinia with choanal atresia and microphthalmia syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at